Individual #00207525

ID_report Patient 2
Reference PubMed: Altassan et al., 2018
Remarks Patient 1's younger brother
Gender M
Consanguinity no
Country -
Population -
Age at death >04y (later than 4 years)
VIP -
Data_av -
Treatment Anti-epileptic medications. Surgical correction of strabismus.
Panel size 1
Diseases HPMRS1
Owner name Philippe Campeau
Database submission license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 InternationalCreative Commons License
Created by Philippe Campeau
Date created 2018-11-23 18:43:55 +01:00 (CET)
Date last edited N/A


Phenotypes

hyperphosphatasia, with mental retardation syndrome, type 1 (HPMRS-1, glycosylphosphatidylinositol deficiency, type 2 (GPIBD-2)) (HPMRS1;GPIBD2)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000155303 Global DD. Tonic-clonic seizures. Strabismus (was surgically corrected). Coarse facial features (high hairlines, hypertelorism, epicanthal folds, horizontal nystagmus, depressed nasal bridge, delayed teeth eruption, everted and partially bifid lower lip, folded ears, and irregular hypopigmented skin margins surrounding the eyes and the nose.) Spastic lower limbs, bilateral brachydactyly, severe clinodactyly of both fifth fingers and toes and dry eczematous skin. High ALP level (454 U/L). No chest deformity or organomegaly. - - Familial, autosomal recessive 00y04m - - - - Philippe Campeau



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000208563 DNA SEQ - Commercially available multigene panel for intellectual disability (GeneDx), Sanger sequencing  PIGL 2 Philippe Campeau



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
17 Unknown +/. - pathogenic g.16120600G>A g.16217286G>A - - PIGL_000015 Compound heterozygous. The first variant (c.60G > A; p.Trp20Ter; W20X) is a nonsense variant and was interpreted as pathogenic as it causes loss of normal protein function through truncation or nonsense-mediated mRNA decay. - - - Germline/De novo (untested) - - - - - Philippe Campeau PIGL - - - - - NM_004278.3:c.60G>A - r.(?) p.(Trp20*) - - - - - - - - - - - - - -
17 Unknown +/. - pathogenic g.16137311C>T g.16233997C>T - - PIGL_000016 Compound heterozygous. This second variant is a missense (c.262C > T; p.Arg88Cys; R88C) variant. In silico analysis predicted it as likely damaging the protein structure and function. - - - Germline/De novo (untested) - - - - - Philippe Campeau PIGL - - - - - NM_004278.3:c.262C>T - r.(?) p.(Arg88Cys) - - - - - - - - - - - - - -
Legend   How to query